1 / 7ITC | British American Tobacco (BAT) on Tuesday said the company will sell up to 3.5% of its stake in ITC through block deals, offering shares at a price range of ₹384-400.25 per share. This represents a 5% discount to the current market price (CPM). The deal is estimated to be worth ₹16,775 crore.
2 / 7Vedanta | Markets watchdog SEBI on Tuesday ordered Vedanta India Ltd, earlier known as Cairn India Ltd to pay Cairn UK Holdings Ltd (CUHL) ₹77.62 crore plus a simple interest of 18% per annum, for delayed payment of dividends. The order comes after SEBI received a complaint on April 13, 2017, from Cairn UK Holdings Ltd alleging non-payment of dividends.
3 / 7ICICI Pru AMC | The company on Tuesday said it has stopped lumpsum investment mid- and small-cap schemes effective from March 14, 2024. ICICI Prudential Trust Ltd has approved to temporarily discontinue subscriptions in the schemes of ICICI Prudential Midcap Fund and ICICI Prudential Small-Cap Fund from March 14 till further notice.
4 / 7Shalby | Multi-speciality hospital chain on Tuesday said it will acquire a 100% stake in Healers Hospital Private Ltd (HHPL) for ₹104 crore. The acquisition will be carried out through a secondary acquisition from the existing shareholders of HHPL. The transaction is expected to be completed within 30 days post-approval.
5 / 7Glenmark Life Sciences | Ahmedabad-based Nirma, known for its detergents, soap, and dishwashing bars, on Tuesday said it has completed the acquisition of a 75% stake in Glenmark Life Sciences. The company is engaged in the business of development, manufacturing, and sale of Active Pharmaceutical Ingredients and intermediaries and contract development and manufacturing organisation services for APIs.
6 / 7Muthoot Capital Services | Kerala-based two-wheeler loan company on Tuesday said it has partnered with Greaves Finance Ltd, a wholly-owned subsidiary of Greaves Cotton Ltd. The collaboration, facilitated through Greaves Finance's EV-focused lending platform ‘evfin,’ aims to enhance the accessibility of financing solutions for electric two-wheelers across the country.
7 / 7Aurobindo Pharma | The company on Tuesday said Eugia Pharma Specialities, a wholly owned subsidiary of the company, has started distribution of aseptic products manufactured at Unit III, which was temporarily stopped. "We also expect to start commercial production from the aseptic lines of the said facility in a phased manner beginning next week and to re-start all the lines by April 15, 2024," it said.
